Loading...
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
DRTSW
DRTSW News & Events
-
Add to Watchlist
Trade DRTSW
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Forecast
Technical
Valuation
Financials
Earnings
Should I Buy
News
DRTSW News
Alpha Tau Achieves First Patient Treatment in U.S. Multi-Center Clinical Trial for Pancreatic Cancer
Sep 02 2025
Newsfilter
Alpha Tau to Attend Five Investor Conferences in September
Aug 27 2025
Newsfilter
Alpha Tau Announces First Quarter 2025 Financial Results and Provides Corporate Update
May 19 2025
Newsfilter
Alpha Tau to Participate in May Investor Conferences
May 06 2025
Newsfilter
Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alliance with Oramed Pharmaceuticals
Apr 28 2025
Newsfilter
Alpha Tau Receives Medical Device Single Audit Program (MDSAP) Certification
Feb 24 2025
Newsfilter
Alpha Tau Announces Cornerstone Interim Data Across Multiple Clinical Trials to be Shared at R&D Update Day
Jan 27 2025
Newsfilter
Alpha Tau Announces Upcoming Presentation of New Data at 2025 ASCO GI Symposium and at Company R&D Update Day
Dec 18 2024
Newsfilter
Show More News
DRTSW Events
No data
DRTSW Monitor News
No data
DRTSW Earnings Analysis
No Data
People Also Watch
